Irbesartan vs Nivolumab

## Irbesartan vs Nivolumab: Overview

This comparison examines the pharmacological differences between **Irbesartan** and **Nivolumab**.

## Mechanism of Action

**Irbesartan**: Selective non-competitive angiotensin II type 1 receptor antagonist.

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Irbesartan — 11-15 hours; Nivolumab — 27 days.

## Chemical Properties

**Molecular Formula**: Irbesartan — C25H28N6O; Nivolumab — N/A.

**Molecular Weight**: Irbesartan — 428.5320 g/mol; Nivolumab — N/A.

**Type**: Irbesartan — Small molecule; Nivolumab — Antibody.